School of Medicine
Showing 10,401-10,450 of 12,993 Results
-
Andrew Young Shin
Clinical Professor, Pediatrics - Cardiology
Current Research and Scholarly InterestsSURF PROGRAM
The SURF program is an innovative collaboration between LPCH, Stanford University Hospital and the Stanford School of Engineering. The program has focused on improving quality and safety of patient care, improving hospital operations and promoting clinical effectiveness utilizing contemporary technologies such as machine learning, mathematical optimization, simulation and a variety of statistical, probabilistic and computational tools. The program has 2 independent funding mechanism to primarily improve patient care/hospital operations and improve academics for faculty within the department of Pediatrics at LPCH.
https://surf.stanford.edu/
CLINICAL EFFECTIVENESS
The Clinical Effectiveness (CE) Program is a funded program that aims to understand and improve unnecessary variation in healthcare delivery in order to optimize quality of care and reduce wasteful expenditures. The CE program has developed innovative programs such as Target Based Care, an award-winning intervention to reduce variation in hospital length of stay and currently a multi-center trial involving more than 20 hospitals in North America. In 2016, the CE program included the first CE fellowship program in a pediatric training program with 3 cycles of graduates. The CE program is supported by LPCH and a philanthropic gift by Susan Choe and Thomas Tobiason. -
Parveen Shiraz, MD
Instructor, Medicine - Blood & Marrow Transplantation
Current Research and Scholarly InterestsI am a physician-scientist in the Division of Blood and Marrow Transplantation/Cell Therapy (BMT/CT) at Stanford University. The dearth of effective therapies for refractory leukemias and the curative potential of hematopoietic stem cell transplant (HCT) prompted me to pursue a career in HCT. As a BMT clinician, caring for patients suffering from the toxicities of HCT and post-HCT leukemia relapse motivated me to pursue laboratory and translational research in search of less toxic and more effective HCT conditioning strategies. In 2021, I became an instructor in the laboratory of Dr. Judith Shizuru who specializes in CD117 antibody based non-toxic HCT conditioning. We have produced anti-CD117 multi-antigen targeting and NK, macrophage or T cell engaging antibodies to eradicate residual leukemic clones and permit engraftment of normal donor HSCs. Our invitro studies are already showing superiority of the multiantigen targeting NK engaging antibodies and invivo studies of these antibodies in xenograft models of myelodysplastic syndrome and acute myeloid leukemia are in progress.
-
Judith Shizuru
Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Current Research and Scholarly InterestsTransplantation of defined populations of allogeneic hematopoietic cells. Specifically, the way in which hematopoietic cell grafts alter antigen specific immune responses to allo-, auto- and viral antigens. The cellular and molecular basis of resistance to engraftment of allogeneic hematopoietic stem cells.
-
Eugene Shkolyar, MD
Clinical Assistant Professor, Urology
BioEugene Shkolyar, MD is a urologic oncologist who specializes in treating patients with bladder, prostate, kidney, and testis cancers. He is a clinical assistant professor in the Department of Urology at the Stanford School of Medicine.
Dr. Shkolyar has expertise in open, endoscopic, and robotic surgery and in caring for patients with complex urologic oncology needs. Dr. Shkolyar is actively engaged in translational research, with a particular interest in integrating artificial intelligence into bladder cancer treatment and the development of novel biomarkers for cancer detection. His commitment to continual innovation ensures that his patients have access to the latest and most effective treatment options.
Dr. Shkolyar was born in Kyiv, Ukraine, and raised in New York. He attended Cornell University for his undergraduate education and went on to UCLA for medical school. Following medical school, Dr. Shkolyar completed a residency in urology at Stanford, where he developed his interest in urologic oncology, translational bladder cancer research and teaching. He went on to complete a two-year fellowship in urologic oncology at Stanford School of Medicine gaining additional skills in management of complex urologic cancers. Dr. Shkolyar is the recipient of numerous honors and awards, including membership in the Alpha Omega Alpha medical honors society and a research scholar award from the Urology Care Foundation. In addition, he has authored and co-authored numerous publications in urology, artificial intelligence, and device development.
Dr. Shkolyar is a member of the Society of Urologic Oncology, the American Society of Clinical Oncology, the American Urological Association, and the European Association of Urology. -
Mir S Adil
Postdoctoral Scholar, Cardiology
BioDr. Adil is a Postdoctoral Scholar at RabLab in the cardiopulmonary division. He has a PharmD from Jawaharlal Nehru Technological University Hyderabad (India) and a PhD in Clinical & Experimental Therapeutics from University of Georgia. He has a pre-doctoral experience of three years as a Scientific Writer, Clinical Research Co-ordinator and Clinical Pharmacologist. He has also worked as a Research Pharmacologist at Charlie Norwood VA Medical Center during his PhD. He has served as a Consulting Editor for Dove Medical Press Journals and he has been serving as Editor, Editorial Board Member and Reviewer for several other journals. He has nearly 50 peer-reviewed publications to his name that include book chapters, review and research articles. Besides publications, he has reviewed more than 20 manuscripts for some reputed journals.
-
Zahra Shokri Varniab
Postdoctoral Scholar, Radiology
BioZahra Shokri Varniab, MD, studied medicine at Tehran University of Medicine Sciences, Iran, and earned her medical degree in 2020. Her goal in novel cellular and molecular imaging is to develop novel in vivo imaging approaches to visualize, characterize and quantify molecular and cellular processes involved in developing brain tumors. She intends to utilize non-invasive imaging techniques to assess tumor microenvironment to understand their role in cancer, develop a method for determining tumor profiles, and also using brain MR Imaging to assess treatment response. She hopes cancer to be history.
-
William Shomali
Clinical Assistant Professor, Medicine - Hematology
BioDr. Shomali is a clinical assistant professor of Hematology at Stanford University School of Medicine. He is board certified in hematology & medical oncology.
Dr. Shomali specializes in the treatment of blood cancers such as myeloproliferative neoplasms and myelodysplastic syndromes. He aims to provide compassionate, personalized, and evidence-based care to each patient.
Dr. Shomali received his medical degree from the University of Jordan, followed by a postdoctoral fellowship at MD Anderson Cancer Center where he studied infections in cancer patients and the role of biomarkers in defining tumor fever. He completed his residency training in Internal Medicine at the Cleveland Clinic Foundation where he served as a Chief Medical Resident. He then joined Stanford University for his combined Hematology & Oncology fellowship training.
Dr. Shomali’s research interests include the study of novel agents in myeloproliferative neoplasms and myelodysplastic syndromes. He developed investigator-initiated clinical trials for patients with eosinophilic neoplasms and advanced myelofibrosis. In addition, he co-authored several papers and book chapters discussing the care of patients with cancer. His work has been presented in national meetings and published in peer reviewed journals including Blood, American Journal of Hematology, British Journal of Hematology, Leukemia & Lymphoma, and Cancer.
Among his honors, Dr. Shomali received the Cleveland Clinic Excellence in Teaching Award and was named to the Alpha Omega Alpha Medical Honor Society. He has received a Young Investigator Award from the Conquer Cancer Foundation, an NIH Institutional National Research Service Award, and a Stanford Cancer Institute Fellowship Award.
Dr. Shomali is a member of the American Society of Hematology and the American Society of Clinical Oncology. -
Mahasish Shome
Postdoctoral Scholar, Genetics
BioDr. Mahasish Shome is interested in understanding the underlying mechanism of disease progression. He uses various omics profiling to identify biomarkers relevant to the disease. He studies antibodies, cytokines, proteins and metabolites profile to decipher the connection of disease with markers. This helps in early diagnosis, understanding disease state and drug/vaccine effectiveness.
-
Stanford Shoor
Clinical Professor, Medicine - Immunology & Rheumatology
Current Research and Scholarly InterestsPatient Centered Care in Rheumatic Disease
Sarcoidosis -
Jade Shorter, MD, MSHP
Clinical Associate Professor, Obstetrics & Gynecology
BioDr. Shorter specializes in complex family planning, early pregnancy management, and general gynecology. She is committed to improving the continuity of care for patients with early pregnancy complications and serves as the Director of the Early Pregnancy Assessment Program. Her clinical research interests include improving patients’ experience with abortion and early pregnancy care, addressing reproductive health disparities, and promoting health equity.
-
Linda M. Dairiki Shortliffe
Stanley McCormick Memorial Professor in the School of Medicine, Emerita
Current Research and Scholarly InterestsThe timing for intervention in obstruction in the infant and child is poorly understood.Our group has been interested in trying to define the risks that may be involved in obstructive and infectious uropathies and discovering early signs of damage to the urinary tract and kidney. We have explored ways of imaging the urinary tract using nonionizing radiation (US, MRI). We have studied the relationships of sex steroid hormones, pregnancy, reflux, urinary tract infection and urinary tract function.
-
Joseph Shrager
Professor of Cardiothoracic Surgery
Current Research and Scholarly InterestsIn clinical research, Dr. Shrager studies outcomes in a variety of areas within Thoracic Surgery including: parenchyma-sparing operations and minimally invasive resections for lung cancer, transcervical thymectomy for myasthenia gravis, diaphragm plication, and surgical treatment of emphysema.
Dr. Shrager's lab is focused on the impact of disease states upon the diaphragm. His group published the seminal paper (NEJM) describing diaphragm atrophy assoc'd with mechanical ventilation. -
Aimee D. Shu
Clinical Associate Professor, Medicine - Endocrinology, Gerontology, & Metabolism
BioI am an endocrinologist with particular interests in reproductive and bone health.
I enjoy treating patients with menstrual disorders, menopause, fractures, osteoporosis, parathyroid imbalance, and calcium imbalance.
As a certified menopause practitioner (North American Menopause Society), I help women fine-tune their health at the mid-life transition. Some women transition through menopause with ease, while others experience challenging symptoms like hot flashes, slowed metabolism, and mood changes. This transition period provides a good opportunity to create a "game plan" for preserving future health. It also marks the beginning of natural bone loss, leaving one more susceptible to fragility fractures.
I provide individualized treatment plans for bone health to men and women of all ages, including for those with specific challenges such as chronic steroid use. As a certified clinical densitometrist (International Society for Clinical Densitometry), I personally review all my patients' bone density scan images. Thus, please bring any non-Stanford bone density scan images to your appointment with me.
Appointments with me are available on Stanford's main campus (300 Pastuer Drive) and at the Stanford Medicine Outpatient Center (450 Broadway, Redwood City). -
Yasuhiro Shudo, MD, PhD
Clinical Assistant Professor, Cardiothoracic Surgery
BioDr. Shudo is a board-certified cardiothoracic surgeon and clinical assistant professor in the Department of Cardiothoracic Surgery at Stanford University School of Medicine.
His clinical focus is the surgical treatment of end-stage cardiopulmonary failure, including heart transplant, heart-lung transplant, lung transplant, mechanical circulatory support (MCS), and extracorporeal membrane oxygenation (ECMO). He has published numerous landmark papers
and chapters.
Dr. Shudo also performs mitral valve repair/replacement (MVR), aortic valve replacement (AVR), complex valve surgery, coronary artery bypass graft (CABG) surgery, reoperative cardiac surgery, minimally invasive surgery, and transcatheter aortic valve replacement (TAVR).
Dr. Shudo is fully committed to innovative, comprehensive, and compassionate care for each patient he treats. -
Ann Shue, MD
Clinical Assistant Professor, Ophthalmology
Clinical Assistant Professor (By courtesy), PediatricsBio**Dr. Shue is taking new patients for glaucoma, cataracts, and adult strabismus.**
Ann Shue, MD, is a Clinical Assistant Professor of Ophthalmology at Stanford University School of Medicine, where she specializes in glaucoma, pediatric ophthalmology, and adult strabismus, a unique combination of subspecializations practiced by few surgeons worldwide. She is a board-certified ophthalmologist who completed fellowships in glaucoma at Yale University and pediatric ophthalmology and adult strabismus at Duke University. She practices at the Stanford Byers Eye Institute and the Lucile Packard Children's Hospital.
Dr. Shue loves seeing patients of all ages with eye problems big or small, including glaucoma due to any reason, glaucoma suspicion, family history of glaucoma, cataracts, strabismus (eye misalignment) or double vision from any cause, including after eye surgeries. She completed her ophthalmology residency at the University of Pittsburgh and an internal medicine internship at UCSF Fresno. She holds a medical degree from University of California, Irvine and an undergraduate degree in biology from Yale University.
Dr. Shue is a member of the American Glaucoma Society, the American Association for Pediatric Ophthalmology and Strabismus, and the UK Paediatric Glaucoma Society. She is active in presenting at regional and national conferences. She is the author of several journal articles and recently wrote two textbook chapters on pediatric glaucoma and pediatric glaucoma surgery. -
Lawrence Shuer, MD
Professor of Neurosurgery
Current Research and Scholarly InterestsI have clinical research interests in the surgical treatment of epilepsy. I am also interested in new developments in the treatment of craniosynostosis a congenital abnormality of infant's skulls
-
Takudzwa Shumba
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioDr. Takudzwa Shumba is a family medicine clinician-educator with particular interests in global health equity, preventative medicine, women's health, pediatrics and integrative medicine. She was born and raised in Zimbabwe. Prior to beginning medical school at Stanford, she completed a Master's in Public Health at Yale, with a focus in global health. She has been involved in public health projects in Zimbabwe, Hong Kong and mainland China and Kenya. She completed her residency at Stanford Health Care - O'Connor Hospital Family Medicine in San Jose, prior to joining faculty at Stanford Family Medicine. LGBTQQI friendly. After several years as a continuity primary care provider at Stanford Family Medicine, she transitioned to providing quality same day access for acute patient needs.
She is currently Co-director of the Leadership Education in Advancing Diversity (LEAD) program, Associate Director of the Clinical Summer Internship (CSI), Course Director of the undergraduate seminar “Decolonizing Global Health,” and Co-Director of the "Social and Environmental Determinants of Health" elective. She is a California Health Care Foundation (CHCF) Fellow (2020-2022) and Presidential Leadership Scholar (2022). She previously served as the Primary Care and Population Health (PCPH) Division Global Health faculty lead and PCPH DEI faculty lead.
